Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

Valued at a market cap of $14.8 billion, Viatris Inc. (VTRS) is a healthcare company that operates in four segments: ...

CEO's use of Eli Lilly's (LLY) weight loss drug Mounjaro over Novo Nordisk's (NVO) rival product, Ozempic. Read more here.

The industry’s intellectual property manipulations are stealing from your pockets—and limiting the benefits of the Biden ...

As Gov. Gavin Newsom enters the second half of his final term, healthcare emerges as his most ambitious but glaringly ...

Technological advancements like AI, machine learning and precision medicine are set to revolutionise drug discovery, ...